BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38263362)

  • 21. m6A demethylase FTO renders radioresistance of nasopharyngeal carcinoma via promoting OTUB1-mediated anti-ferroptosis.
    Huang WM; Li ZX; Wu YH; Shi ZL; Mi JL; Hu K; Wang RS
    Transl Oncol; 2023 Jan; 27():101576. PubMed ID: 36343416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue.
    Nakagawa N; Tanaka K; Sonohara F; Kandimalla R; Sunagawa Y; Inokawa Y; Takami H; Hayashi M; Yamada S; Kanda M; Tanaka C; Nakayama G; Koike M; Kodera Y
    Anticancer Res; 2020 Dec; 40(12):6665-6676. PubMed ID: 33288560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5.
    Huang Y; Yan J; Li Q; Li J; Gong S; Zhou H; Gan J; Jiang H; Jia GF; Luo C; Yang CG
    Nucleic Acids Res; 2015 Jan; 43(1):373-84. PubMed ID: 25452335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases.
    You Y; Fu Y; Huang M; Shen D; Zhao B; Liu H; Zheng Y; Huang L
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA demethylase Alkbh5 is widely expressed in neurons and decreased during brain development.
    Du T; Li G; Yang J; Ma K
    Brain Res Bull; 2020 Oct; 163():150-159. PubMed ID: 32717204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. m
    Liu J; Ren D; Du Z; Wang H; Zhang H; Jin Y
    Biochem Biophys Res Commun; 2018 Aug; 502(4):456-464. PubMed ID: 29842885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell Differentiation and Aging Lead To Up-Regulation of FTO, While the ALKBH5 Protein Level Was Stable During Aging but Up-Regulated During in vitro-Induced Cardiomyogenesis.
    Krejčí J; Arcidiacono OA; Čegan R; Radaszkiewicz K; Pacherník J; Pirk J; Pešl M; Fila P; Bártová E
    Physiol Res; 2023 Aug; 72(4):425-444. PubMed ID: 37795886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of two novel ALKBH5 selective inhibitors that exhibit uncompetitive or competitive type and suppress the growth activity of glioblastoma multiforme.
    Takahashi H; Hase H; Yoshida T; Tashiro J; Hirade Y; Kitae K; Tsujikawa K
    Chem Biol Drug Des; 2022 Jul; 100(1):1-12. PubMed ID: 35384315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. m
    Tang B; Yang Y; Kang M; Wang Y; Wang Y; Bi Y; He S; Shimamoto F
    Mol Cancer; 2020 Jan; 19(1):3. PubMed ID: 31906946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. m
    Jin D; Guo J; Wu Y; Yang L; Wang X; Du J; Dai J; Chen W; Gong K; Miao S; Li X; Sun H
    Mol Cancer; 2020 Feb; 19(1):40. PubMed ID: 32106857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-141-3p promotes malignant progression in prostate cancer through AlkB homolog 5-mediated m
    Li X; Liu B; Wang S; Li J; Ge X
    Chin J Physiol; 2023; 66(1):43-51. PubMed ID: 36814156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome.
    Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y
    Front Med (Lausanne); 2022; 9():959388. PubMed ID: 36465909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ALKBH5 suppresses malignancy of hepatocellular carcinoma via m
    Chen Y; Zhao Y; Chen J; Peng C; Zhang Y; Tong R; Cheng Q; Yang B; Feng X; Lu Y; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2020 Aug; 19(1):123. PubMed ID: 32772918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ALKBH5 activates FAK signaling through m6A demethylation in
    Sun R; Yuan L; Jiang Y; Wan Y; Ma X; Yang J; Sun G; Zhou S; Wang H; Qiu J; Zhang L; Cheng W
    Theranostics; 2023; 13(2):833-848. PubMed ID: 36632222
    [No Abstract]   [Full Text] [Related]  

  • 35. ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m
    Zhang X; Wang F; Wang Z; Yang X; Yu H; Si S; Lu J; Zhou Z; Lu Q; Wang Z; Yang H
    Ann Transl Med; 2020 May; 8(10):646. PubMed ID: 32566583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. m
    Takemoto S; Nakano M; Fukami T; Nakajima M
    Biochem Pharmacol; 2021 Nov; 193():114766. PubMed ID: 34536357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. m
    Zhang S; Zhao BS; Zhou A; Lin K; Zheng S; Lu Z; Chen Y; Sulman EP; Xie K; Bögler O; Majumder S; He C; Huang S
    Cancer Cell; 2017 Apr; 31(4):591-606.e6. PubMed ID: 28344040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N
    Zhu Z; Qian Q; Zhao X; Ma L; Chen P
    Gene; 2020 Mar; 731():144348. PubMed ID: 31927006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N6-methyladenosine RNA demethylase ALKBH5 is testis-specifically downregulated in hybrid male sterile dzo and is a target gene of bta-miR-200a.
    Chen H; Zhang J; Yan Y; Zhu C; Wang L; Fu S; Zuo F; Zhang GW
    Theriogenology; 2022 Jul; 187():51-57. PubMed ID: 35504087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. M
    Zheng L; Li Z; Wang B; Sun R; Sun Y; Ren J; Zhao J
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.